30-Day postoperative COVID-19 outcomes in 398 patients from regional hospitals utilising a designated COVID-19 minimal surgical site pathway.


Journal

Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860

Informations de publication

Date de publication:
Jun 2021
Historique:
pubmed: 7 5 2021
medline: 4 6 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

Postoperative pulmonary complications and mortality rates during the COVID-19 pandemic have been higher than expected, leading to mass cancellation of elective operating in the UK. To minimise this, the Guy's and St Thomas' Hospital NHS Foundation Trust elective surgery hub and the executive team at London Bridge Hospital (LBH) created an elective operating framework at LBH, a COVID-19 minimal site, in which patients self-isolated for two weeks and proceeded with surgery only following a negative preoperative SARS-CoV-2 polymerase chain reaction swab. The aim was to determine the rates of rates of postoperative COVID-19 infection. The collaboration involved three large hospital trusts, covering the geographic area of south-east London. All patients were referred to LBH for elective surgery. Patients were followed up by telephone interview at four weeks postoperatively. Three hundred and ninety-eight patients from 13 surgical specialties were included in the analysis. The median age was 60 (IQR 29-71) years. Sixty-three per cent (252/398) were female. In total, 78.4% of patients had an American Society of Anesthesiologists grade of 1-2 and the average BMI was 27.2 (IQR 23.7-31.8) kg/m The risk of contracting COVID-19 in our elective operating framework was very low. We demonstrate that high-volume major surgery is safe, even at the peak of the pandemic, if patients are screened appropriately preoperatively.

Identifiants

pubmed: 33956529
doi: 10.1308/rcsann.2020.7072
pmc: PMC10335038
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-403

Références

Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Eur J Cardiothorac Surg. 2001 Oct;20(4):694-9
pubmed: 11574210
Br J Surg. 2020 Aug;107(9):1097-1103
pubmed: 32293715
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Zhonghua Wai Ke Za Zhi. 2020 Feb 14;58(0):E001
pubmed: 32057212
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
Ann Thorac Surg. 2020 Aug;110(2):718-724
pubmed: 32417195
World J Emerg Surg. 2020 Apr 7;15(1):25
pubmed: 32264898
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Ann Surg. 2021 Feb 1;273(2):e39-e40
pubmed: 32433295
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
BMJ. 2020 Jun 30;369:m2539
pubmed: 32605907
EClinicalMedicine. 2020 Jun 03;23:100404
pubmed: 32632416

Auteurs

Smy Chong (S)

London Bridge Hospital, UK.

Rky Hung (R)

London Bridge Hospital, UK.

A Gwozdz (A)

London Bridge Hospital, UK.

S Irwin (S)

Guy's and St Thomas' Hospital NHS Foundation Trust, UK.

J Eastbury (J)

London Bridge Hospital, UK.

T Cross (T)

London Bridge Hospital, UK.

K Ahmed (K)

London Bridge Hospital, UK.

C Taylor (C)

Guy's and St Thomas' Hospital NHS Foundation Trust, UK.

S D Goldenberg (SD)

Guy's and St Thomas' Hospital NHS Foundation Trust, UK.

J Sanderson (J)

Guy's and St Thomas' Hospital NHS Foundation Trust, UK.

J Olsburgh (J)

Guy's and St Thomas' Hospital NHS Foundation Trust, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH